A quantitative angiogenesis model for efficacy testing of chemopreventive agents

Anticancer Research

Volumn 21, Issue 6 A, 2001, Pages 3829-3837

  Sharma, Sheela ^a   Ghoddoussi, Mazyar ^a   Gao, Pu ^a   Kelloff, Gary J ^a   Steele, Vernon E ^a   Kopelovich, Levy ^a  

^a ALION SCIENCE AND TECHNOLOGY   (United States)

Author keywords

Angiogenesis inhibition; Chemopreventive agents; Chorioallantoic membrane; In vivo model

Indexed keywords

ACETYLSALICYLIC ACID; ALITRETINOIN; BOWMAN BIRK INHIBITOR; CAVEOLIN 1; EFLORNITHINE; FENRETINIDE; ISOTRETINOIN; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHOTRANSFERASE; PIROXICAM; PROSTAGLANDIN SYNTHASE; RETINOIC ACID; RETINOID; RETINOID X RECEPTOR; SULINDAC; SULINDAC SULFIDE; SULINDAC SULFONE; TAMOXIFEN; THALIDOMIDE; TRANSFORMING GROWTH FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CHORIOALLANTOIS; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFICACY; EMBRYO; IMAGE ANALYSIS; MALIGNANT TRANSFORMATION; MODEL; NONHUMAN; PRIORITY JOURNAL; PROTECTION; SYRIAN HAMSTER;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; CELL LINE, TRANSFORMED; CHICK EMBRYO; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; MESOCRICETUS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 0035569113     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. What is the evidence that tumors are angiogenesis dependent?
2. Neovascularization in clinical stage A testicular germ cell tumor: Prediction of metastatic disease
3. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer
4. Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer
5. 3: A new prognostic indicator in breast cancer
6. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma
7. Tumour vascularity - A novel prognostic factor in advanced cervical carcinoma
8. Tumor angiogenesis as a prognostic factor in cervical carcinoma
9. Angiogenesis of cervical neoplasia
10. The prognostic significance of tumour vascularity in intermediate thickness (0.76-4.0 mm) melanoma. A quantitative histologic study
11. Inhibitors of angiogenesis in a clinical perspective
12. Induction of angiogenesis during the transition from hyperplasia to neoplasia
13. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
14. Microvessel density and distribution in ductal carcinoma in situ of the breast
15. Angiogenesis in colorectal tumors: Microvessel quantitation in adenomas and carcinomas with clinicopathological correlations
16. Angiogenic activity as a marker of neoplastic and preneoplastic lesions of the human bladder
17. Demonstration and characterization of the angiogenic properties of cervical dysplasia
18. Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia
19. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia
20. Tumor-induced angiogenesis: Lack of inhibition by irradiation
21. Avascular and vascular phases of tumor growth in the chick embryo
22. Tumor growth and neovascularization: An experimental model using rabbit cornea
23. Angiogenic and invasive properties of neurofibroma Schwann cells
24. Role of chromosome loss in ras/myc-induced Syrian hamster tumors
25. Vascularization of normal and neoplastic tissues grafted to the chick chorioallantois
26. The prevention of colorectal cancer by aspirin use
27. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
28. Role of BAX in the apoptotic response to anticancer agents
29. Non-steroidal antiinflammatory drug gastropathy: Causes and treatment
30. Synergistic antiallodynic effects of spinal morphine with ketorolac and selective COX-1 and COX-2 inhibitors in nerve-injured rats
31. Selective targeting of cyclooxygenase-2 reveals its role in renal medullary interstitial cell survival
32. PPARδ is an PAC-regulated target of nonsteroidal anti-inflammatory drugs
33. Par-4, a proapoptotic gene, is regulated by NSAIDs in human colon carcinoma cells
34. Colon cancer chemopreventive drugs modulate integrin-mediated signaling pathways
35. Sulindac sulfide inhibits Ras signalling
36. Inhibition of angiogenesis by sulindac and its sulfone metabolite (FGN-1): A potential mechanism for their antineoplastic properties
37. Retinoid and carotenoid angiogenesis: A possible explanation for enhanced oral carcinogenesis
38. Transforming growth factor alpha (TGF-alpha) expression in dysplastic oral leukoplakia: Modulationby 13-cis-retinoicacid
39. Retinoic acid normalizes the increased gene transcription rate of TGF-α and EGFR in head and neck cancer cell lines
40. Chemoprevention of rat prostate carcinogenesis by 9-cis-retinoic acid
41. 9-cis-retinoic acid decreases the level of its cognate receptor, retinoid X receptor, through acceleration of the turnover
42. Retinoids, interferon alpha, 1, 25-dihydroxyvitamin D3 and their combination inhibit angiogenesis induced by non-HPV-harboring tumor cell lines. RAR alpha mediates the antiangiogenic effect of retinoids
43. In vivo inhibition of angiogenesis and induction of apoptosis by retinoic acid in squamous cell carcinoma
44. Inhibition of angiogenesis through modulation of collagen metabolism
45. Fenretinide and its relation to cancer
46. Carcinoma cell lines resistant for growth inhibition and apoptosis to retinoic acid are responsive to 4-hydroxy-phenyl-retinamide: Correlation with tissue transglutaminase
47. Treatment of prostate cancer in the rat with synthetic retinoid fenretinide
48. Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, angiogenic in vivo
49. Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and caveolae formation in vascular endothelial cells. Angiogenesis inhibitors block vascular endothelial growth factor-induced down-regulation of caveolin-1
50. Thalidomide may impede cell migration in primates by down-regulating integrin beta-chains: Potential therapeutic utility in solid malignancies, proliferative retinopathy, inflammatory disorders, neointimal hyperplasia, and steoporosis
51. Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas
52. Continuous low dose Thalidomide: A phase II study in advanced melanoma, renal cell, ovarian and breast cancer
53. Thalidomide is an inhibitor of angiogenesis
54. Effect of modifiers of arachidonic acid metabolism on radiation transformation and eicosanoid formation in C3H/10T1/2 cells
55. Cancer prevention by protease inhibitors
56. A proteolytic activity in a human breast cancer cell line which is inhibited by the anticarcinogenic Bowman-Birk protease inhibitor
57. Polyamines prevent DFMO-mediated inhibition of angiogenesis
58. Tamoxifen enhances cell death in implanted MCF7 breast cancer by inhibiting endothelium growth
59. Tumor angiogenesis (TA) quantitation by factor VIII-related antigen immunocytochemistry: A new, highly significant, and independent prognostic indicator (PI) in early stage breast carcinoma (ESBC)
60. A Phase II study of high-dose tamoxifen in patients with hormone-refractory prostate cancer
61. A Phase I study of high-dose tamoxifen for the treatment of refractory malignant gliomas of childhood
62. Effects of tamoxifen on growth and apoptosis of estrogen dependent and independent human breast cancer cells
63. Effects of tamoxifen on telomerase activity in breast carcinoma cell lines
64. 2-Methoxyestradiol, an endogenous estrogen metabolite, induces apoptosis in endothelial cells and inhibits angiogenesis: Possible role for stress-activated protein kinase signaling pathway and fas expression
65. 3 antagonist and inducing apoptosis
66. The antineoplastic ether lipid, s-phosphate, selectively induces apoptosis in human leukemia cells and exhibits antiangiogenesis and apoptosis activity on the chorioallantoic membrane of the chick embryo
67. Evidence for the involvement of endothelial cell integrin alpha Vbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma
68. 3 for angiogenesis
69. v integrins
70. Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane